1. Home
  2. NMFC vs SLBT Comparison

NMFC vs SLBT Comparison

Compare NMFC & SLBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Mountain Finance Corporation

NMFC

New Mountain Finance Corporation

N/A

Current Price

$6.38

Market Cap

636.6M

Sector

Finance

ML Signal

N/A

Logo SL Science Holding Limited Ordinary Shares

SLBT

SL Science Holding Limited Ordinary Shares

N/A

Current Price

$0.54

Market Cap

644.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
NMFC
SLBT
Founded
2010
N/A
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
636.6M
644.9M
IPO Year
2010
2025

Fundamental Metrics

Financial Performance
Metric
NMFC
SLBT
Price
$6.38
$0.54
Analyst Decision
Hold
Analyst Count
7
0
Target Price
★ $8.13
N/A
AVG Volume (30 Days)
★ 705.5K
46.5K
Earning Date
11-02-2026
10-26-2026
Dividend Yield
★ 15.60%
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.31
$0.57
52 Week High
$9.84
$6.25

Technical Indicators

Market Signals
Indicator
NMFC
SLBT
Relative Strength Index (RSI) 31.37 22.09
Support Level N/A N/A
Resistance Level $7.26 $1.75
Average True Range (ATR) 0.17 0.13
MACD -0.05 -0.01
Stochastic Oscillator 10.00 4.94

Price Performance

Historical Comparison
NMFC
SLBT

About NMFC New Mountain Finance Corporation

New Mountain Finance Corp is a closed-end, non-diversified management investment company. It invests in equity interests such as preferred stock, common stock, warrants, or options received in connection with debt investments or may include direct investment in the equity of private companies. The company's investment objective is to generate current income and capital appreciation through sourcing and origination of debt securities at all levels of the capital structure, including first and second-lien debt, notes, bonds and mezzanine securities.

About SLBT SL Science Holding Limited Ordinary Shares

SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.

Share on Social Networks: